New 5-HT2C receptor agonists

By Bishop Michael J   Nilsson Björn M  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite

Pretreatment with 5-HT 1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus

By Compaan J.C.   Groenink L.   Van der Gugten J.   Maes R.A.A.   Olivier B.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R.   Bouml s M.   Jenck F.   Kouml hler C.   Moreau J.-L.   Sleight A.J.   Stadler H.   Wichmann J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Lymphocytic Muscarinic Acetylcholine Receptor in Methylmercury-Induced c-Fos Expression and Apoptosis in Human Leukemic T Cells

By Suriyo Tawit   Thiantanawat Apinya   Chaiyaroj Sansanee   Parkpian Preeda   Satayavivad Jutamaad  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 16, 2008-01 ,pp. : 1109-1123

Taylor & Francis Ltd

Access to resources Recommend Favorite